Use of prokinetic agents or antibiotics is associated with the occurrence of spontaneous bacterial peritonitis in cirrhotic patients

Journal of the Chinese Medical Association : JCMA
Yun-Cheng HsiehHan-Chieh Lin

Abstract

Prokinetics have been shown to improve intestinal bacterial overgrowth and dysmotility in cirrhotic patients. Antibiotics are suggested for high risk patients for prophylaxis of spontaneous bacterial peritonitis (SBP). However, limited studies have investigated the association of SBP and these medications. We examined the association of prokinetics or antibiotics use and the first episode of SBP development in patients with cirrhosis. We conducted a case-crossover study using the Taiwanese National Health Insurance Research Database from 2001 to 2010. A total of 129 cirrhotic patients with SBP were identified (defined as International Classification of Disease-Ninth Revision-CM codes: 571.xx for cirrhosis; 567.2, 567.8, and 567.9 for ascites; 789.5 for SBP). We investigated the short term (defined as 14-day period) effect of prokinetic agents or antibiotics use on SBP development using conditional logistic regressions with the adjustment of potential confounders. The results suggested that prokinetic agents or antibiotics use during the 14 days before SBP were associated with an increased risk of SBP [adjusted odds ratio (OR) = 3.2, 95% confidence interval (CI): 1.02-10.04 for prokinetic agents; and adjusted OR = 2.95, 95% CI: ...Continue Reading

References

Sep 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J LlachJ Rodés
Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Oct 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P GinésJ M Salmerón
May 1, 1994·Gut·C F Doershuk, R C Stern
Jul 1, 1993·Journal of Hepatology·W R Caly, E Strauss
Feb 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C ToledoJ Rodés
Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A PardoM A Gassull
Jan 12, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Javier FernándezJuan Rodés
May 15, 2002·Critical Care Medicine·Konstantin Zedtwitz-LiebensteinWolfgang Graninger
Mar 13, 2003·World Journal of Gastroenterology : WJG·Shun-Cai ZhangWu-Nan Zhu
Apr 20, 2005·Journal of Gastroenterology and Hepatology·Bimaljit S SandhuShiv K Sarin
Aug 24, 2007·The American Journal of Gastroenterology·Keith L ObsteinYu-Xiao Yang
Apr 2, 2009·The American Journal of Gastroenterology·Jasmohan S BajajKia Saeian
Jun 11, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Marco SenzoloAndrew Kenneth Burroughs
Dec 14, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gati A GoelWilliam D Carey
Nov 30, 2012·Journal of Gastroenterology and Hepatology·Abhishek DeshpandeAdrian V Hernandez
Sep 3, 2013·Journal of Hepatology·Reiner WiestMarkus Geuking
Mar 15, 2014·World Journal of Gastroenterology : WJG·Nora SipekiMaria Papp
Jul 31, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gitte DamPeter Jepsen

❮ Previous
Next ❯

Citations

Dec 31, 2019·European Journal of Clinical Investigation·Hanwei LiChristian J Steib

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.